Epicardial adipose tissue (EAT) has been proposed to modulate underlying coronary plaque features. The study aimed to determine the relation between segmental EAT (sEAT) volume, assessed by cardiac magnetic resonance (CMR), and underlying coronary plaque characteristics, as estimated by multidetector computed tomography (CT) (MDCT).
Background
The concept of cardiac adiposity as a novel cardiovascular risk factor has received recently increasing attention. 1 Epicardial adipose tissue (EAT) has been linked to visceral adiposity and several metabolic abnormalities, with scarce inconsistent data relating EAT and hepatic fat. 2 EAT thickness not only predicts cardiovascular risk, but also correlates significantly with the extent and severity of CAD. 3, 4 EAT has been proposed to modulate underlying coronary plaque features through vasocrine and paracrine secretion of inflammatory cytokines, a recently postulated concept of outside-to-inside cellular crosstalk. 1, 5, 6 However, limited controversial data exist regarding the relation between EAT and coronary plaque characteristics. 7 -9 This may be attributed to measurement of pericardial adipose tissue (PAT)-which includes the paracardial fat located on the external surface of pericardium that lack functional interaction with the coronary arteries-in some studies. 9 Moreover, all prior studies correlated either EAT or PAT volume, as measured by MDCT, with the plaque characteristics in the whole coronary artery tree with no further segmental analysis. The current study aimed to (i) determine the relation between segmental peri-coronary EAT (sEAT) volume, assessed by CMR, and underlying coronary plaque characteristics, as estimated by MDCT, and (ii) find out predictors for increased EAT volume.
Methods

Study population
This was a prospective study conducted in Aswan Heart Centre and included 32 male patients (among 167 screened consecutive patients) who were referred for cardiac catheterization because of stable angina pectoris. Eleven age-matched asymptomatic male volunteers with normal electrocardiogram (ECG) and echocardiography, and no smoking, hypertension, or diabetes mellitus served as control group. The following features were considered as exclusion criteria: female gender, insulin-dependent diabetes mellitus, thyroid dysfunction, familial lipoprotein disorders, atrial fibrillation, prior coronary artery bypass grafting surgery or percutaneous coronary stenting, chronic total occlusion of major epicardial coronary arteries, acute coronary syndromes (ACS) within 1 month of presentation, left ventricle (LV) systolic dysfunction (ejection fraction ,40%), known chronic liver disease, serum creatinine .2.0 mg/dL, statins therapy, or un-interpretable images.
A written informed consent was obtained from both study groups. The study complies with the Declaration of Helsinki, and the protocol was approved by the Institutional Research Ethics Committee.
Clinical data
Demographic data were collected and the presence of risk factors for atherosclerosis, diabetes mellitus, hypertension, dyslipidaemia, smoking, was assessed. Framingham risk score was calculated. Anthropometric measurements, weight, height, abdominal waist circumference, and hip circumference, were obtained. 10 BMI and waist to hip ratio (WHR)
were then calculated 10 . Body surface area (BSA) was calculated using
Mosteller formula.
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CMR imaging protocol
All studies were performed with a 3.0 T superconducting magnet (Achieva 3.0T TX, Philips Medical Systems, The Netherlands). A dedicated 16-element, phased-array cardiac coil was used for acquisition of cardiac images. ECG-gated short-axis cine images were acquired using a segmented steady-state free precession to measure LV mass using manual segmentation.
A dark blood prepared T 1 -weighted multislice turbo flash echo (TFE) pulse sequence was used to obtain a transversal four-chamber view images. 12 Imaging parameters were: time of repetition (TR) 6.4 ms, time to echo (TE) 3.8 ms, slice thickness 3 mm with zero interslice gap, and field of view 28.9 × 28.9. The left anterior descending (LAD), left circumflex (LCX), and right coronary (RCA) arteries were then aligned in CAD patients using the three-point plane. Short-axis T 1 -weighted images for the three arteries were obtained. The coronary arteries were divided into 8 segments (3 in LAD, 3 in RCA, and 2 in LCX) based on the classification adopted in the SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) score.
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Total EAT volume measurement EAT area subtended by manual tracing of the contours of the EAT covering both ventricles was obtained in each slice at end-diastole ( Figure 1 ) on a separate Syngo Siemens, Germany workstation. The coronary arteries were also traced in each slice (Figure 1) , and the traced area was subtracted from the firstly measured EAT area to determine accurately the actual EAT area. The EAT area in all slices was then multiplied by the slice thickness (3 mm) to yield EAT volume using the summation of slices method. Finally, EAT volume was indexed to BSA (EAT-i volume). Large EAT-i volume was defined as EAT-i volume .57 cm 3 /m 2 (value greater than the median EAT-i volume in CAD patients).
sEAT volume measurement
For each patient, sEAT volume around the pre-defined 8 coronary segments was measured. The contour of peri-coronary EAT surrounding the coronary artery was outlined similarly in each slice (Figure 2) , and then sEAT volume was quantified using the summation of slices method.
Hepatic magnetic resonance imaging (MRI) imaging protocol and hepatic fat (HF) fraction quantification 
The values were corrected using the spleen and skeletal muscle as reference tissues, because they contain minimal intracellular lipid. Corrected HF fraction was obtained by subtracting the average fat fraction of the spleen and paravertebral muscles from the calculated hepatic fat fraction.
MDCT of coronary arteries
All scans were performed on a 64-slice CT scanner (Philips Medical System, The Netherlands) during a single breath-hold. Oral b-blockers were administered when the resting heart rate exceeds 70 bpm. For CAC scoring, prospective ECG triggering technique at 50-80% of the RR interval was used. Coronary CT angiography was performed by retrospective ECG gating according to the following protocol: tube voltage 100 -140 kV depending on patient's weight; tube current 560 mAs with dose modulation; gantry rotation time 0.33 s; pitch 0.2 -0.44 adapted to HR; collimation 0.6 mm, leading to an isotropic voxel resolution of 0.2 mm 3 . A volume of contrast agent (Iohexol) adjusted for body weight (1.25 cc/kg) was injected continuously at a rate of 6 cc/s. Axial images were reconstructed with 0.75 mm slice thickness and reconstruction increment of 0.4 mm.
CAC score and coronary plaque characteristics evaluation
Regions with an attenuation ≥130 Hounsfield Units (HU) along the course of a coronary artery were identified as CAC using semiautomatic software available on a separate Syngo Via Siemens, Germany workstation. Total and segmental CAC scores were calculated using the method described by Agatston et al.
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The CT data sets were evaluated by an investigator blinded to EAT volume measurements. Plaques were defined as structures .1 mm 2 within and/or adjacent to the coronary artery lumen, which could be clearly distinguished from the vessel lumen and the surrounding pericardial tissue. 16 Plaques in each coronary segment were characterized in terms of (i) Plaque volume, maximum plaque area within each 3-mm section multiplied by section thickness '3 mm'. 17 (ii) Plaque type, calcified 'plaques with .50% calcium', vs. mixed 'plaques with ,50% calcium', vs. non-calcified. 7, 17 ( Figure 3 ) (iii) Severity of luminal diameter stenosis; mild ' , 50% stenosis' vs. moderate '50 -70% stenosis' vs. severe '.70% stenosis'.
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Measurement of serum lipoproteins, adipokines, and homeostatic model assessment for insulin resistance (HOMA-IR) index
Blood samples were collected in serum separator tubes. After clot formation, the samples were centrifuged for 10 min. Serum levels of total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides levels were measured after 12 h fasting. HOMA-IR was calculated using the formula: HOMA -IR = ( fasting glucose, mg/dL× fasting insulin, mU/mL)/405.
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Serum sample was stored at 2208C. The samples were then used for quantitative measurement of adiponectin, leptin, and resistin using RD195023100 Biovendor Human Adiponectin ELISA kit (Biovendor-Laboratorni medicina a.s, Heidelberg, Germany), DIAsource Leptin-EASIA kit (DIAsource Immunoassays S.A. Louvain-la-Neuve, Belgium), and RD191016100 BioVendor Human Resistin ELISA kit (Biovendor-Laboratorni medicina a.s, Heidelberg, Germany), respectively.
Statistical analysis
Statistical analysis was performed using Statistical Package for Social Sciences, version 16 (SPSS 16). Using Shapiro -Wilk test, all quantitative variables were not normally distributed and accordingly are presented as median (range). Qualitative data are presented as number (percentage). Variables were compared between two unrelated samples using Mann-Whitney U test, and between more than two unrelated samples using Kruskal -Wallis H test. Categorical variables were compared using x 2 analysis. Bivariate correlations were performed using Spearman correlation coefficient. Binary logistic regression analysis that included diabetes mellitus, WHR, hepatic fat fraction, HOMA-IR, and serum resistin Segmental peri-coronary EAT volume and coronary plaque characteristics was performed to identify predictors for increased EAT. Comparison of EAT volume among resistin tertiles was performed using KruskalWallis test. Probability value , 0.05 was considered statistically significant.
Results
The clinical and laboratory characteristics of both study groups are shown in Table 1 . No significant difference in age, BMI, WHR, HOMA-IR, or serum lipoproteins level between both study groups. Serum resistin level was significantly higher in CAD patients than in control group. Among all studied indices of adiposity, only EAT-i volume (even after adjustment for LV mass index) was significantly higher in CAD patients compared with control group (P , 0.001) ( Table 2) . EAT-i volume showed significant linear correlations with total CAC score (r ¼ 0.51, P ¼ 0.003) and coronary plaque volume (r ¼ 0. sEAT volume and segmental coronary plaque characteristics
The analysis of all 256 coronary segments was feasible and demonstrated significant, though weak, correlation between sEAT volume and coronary plaque volume (r ¼ 0.32, P ¼ 0.002) in the corresponding coronary segment. Interestingly, sEAT volume was significantly larger in segments that contain plaques compared with those without plaques (9.9 vs. 8. Segmental peri-coronary EAT volume and coronary plaque characteristics P ¼ 0.019), HOMA-IR (3.6 vs. 1.96, P ¼ 0.012), serum resistin level (9.8 vs. 6.5 ng/mL, P , 0.001), and diabetes mellitus (11 vs. 3%, P ¼ 0.004), were significantly higher in CAD patients with large EAT-i volume than those with lower EAT-i volume (Table 3) 
Predictors of increased EAT volume
Discussion
The present study demonstrated significantly higher EAT-i volume in CAD patients than in control group. sEAT volume correlated significantly with segmental CAC score (r ¼ 0.38, P ¼ 0.006) and plaque volume (r ¼ 0.32, P ¼ 0.002). In addition, sEAT volume was significantly larger in segments with mixed than those with calcified or non-calcified plaques (12.1 vs. 10.2 cm 3 vs. 9.5 cm 3 respectively, P ¼ 0.015), and larger in segments with low CT attenuation, noncalcified plaques compared with non-calcified plaques with high CT attenuation (10.5 vs. 8.2 mm 3 , P , 0.001).
To the best of our knowledge, no prior studies have measured peri-coronary EAT volume in CAD patients using CMR, and none have correlated segmental peri-coronary EAT volume with underlying plaque characteristics in the corresponding coronary segment. This is crucial to prove the paracrine role of EAT in the pathogenesis of coronary atherosclerosis. CMR allows precise visualization of the entire pericardium and is well validated for accurate quantification of EAT volume. 19 The study population was highly selected with strict exclusion criteria to avoid the effect of many known confounding variables.
Among all indices of adiposity, only EAT-i volume was significantly higher in CAD patients compared with control group (57.1 vs. 24.5 mm 3 /m 2 , P , 0.001). A direct significant relation was observed in this study between EAT-i volume and total CAC score, independent of conventional cardiovascular risk factors. Moreover, pericoronary EAT volume around the LAD, RCA and LCX arteries correlated significantly with the CAC score in the corresponding artery. CAC score is an excellent surrogate for the extent of coronary atherosclerosis 20 -22 and is an independent predictor of CAD outcome. 20, 23 In concordance with our results, Alexopoulos et al. 7 showed that EAT volume above 71 cm 3 was an independent predictor of CAC score. In addition, de Vos et al. 24 noted that CT-measured peri-coronary EAT thickness around LAD and RCA but not LCX correlated well with CAC in the same artery. Coronary plaque volume has been recently linked to subsequent adverse cardiovascular events in a systematic review of six serial intravascular ultrasound (IVUS) trials. 25 A significant correlation was detected in our study between EAT-i volume and total coronary plaque volume. Moreover, peri-coronary EAT volume around LAD and RCA, but not LCX, showed significant linear correlations with the plaque volume in the corresponding artery. Indeed, none of the previous studies have investigated such relation. The lack of correlation between peri-coronary EAT volume around LCX artery and its plaque volume may be explained by the significantly lower plaque volume and narrow values range in the LCX artery in our study population compared with that in the RCA or LAD arteries (20 vs. 76 vs. 100 mm 3 respectively, P , 0.001). This might not allow studying a wider spectrum of plaque volumes in the LCX artery.
sEAT volume and coronary plaque characteristics
Limited controversial data exist regarding the relation between EAT volume and coronary artery plaque characteristics. Alexopoulos et al. 7 reported significant increase in CT-measured EAT volume with the severity of luminal stenosis (P , 0.001). Morover, Mazurek et al. 26 showed that EAT thickness surrounding LAD was positively related to LAD stenosis and inversely related to LAD minimum luminal diameter in patients with acute myocardial infarction. The current study proved significant difference in sEAT volume according to the severity of luminal stenosis. In addition, sEAT volume was significantly greater in segments with severe stenosis than those with mild or moderate stenosis. Alexopoulos et al. 7 and Dong et al. 27 reported also significant increase in CT-measured EAT volume in patients with mixed or non-calcified plaques compared with those with calcified plaques. Moreover, Ito et al. 8 showed that the highest tertile of EAT volume is an independent predictor for thin-capped fibroatheroma, as estimated by optical coherence tomography. In contrast, Greif et al. 9 did not find significant difference in PAT volume between patients with different types of atherosclerotic plaques. The current study proved significant difference in sEAT volume according to plaque composition in the corresponding coronary segment. sEAT volume was significantly greater in segments with mixed plaques compared with calcified and non-calcified plaques. Interestingly, non-calcified plaques with low CT attenuation were surrounded by significantly larger sEAT volume compared with those with higher CT attenuation. Low CT attenuation seems to be a consistent feature of lipid-rich vulnerable plaques with large necrotic core. 28 This may plausibly support a key role for a new signalling pathway that originates at the peri-coronary EAT and leads to amplification of vascular inflammation and plaque instability. 4 Indeed, a substantial inflammatory infiltrate and significantly higher nuclear factor Kappa beta (NF-kB) and c-Jun N-terminal kinase (JNK) activity has been demonstrated in EAT of patients with CAD. 29, 30 Spotty calcifications are highly prevalent in vulnerable plaques associated with ACS. 31 -33 Calcium increases the shear stress and hence the risk of plaque instability and rupture, and increased incidence of ACS. 34, 35 Resistin and EAT
Resistin is a novel adipokine that has been linked to inflammation and atherosclerosis. The current study demonstrated significantly higher serum resistin level in CAD patients than control group and identified serum resistin level as an independent predictor of large EAT-i volume. To date, no studies have tested the relation between EAT volume and serum resistin level. However, the mRNA expression of resistin has been shown to be three-fold higher in EAT than in gluteal AT, 36, 37 40 and sepsis. 41 However, data reporting the relation between resistin and CAD are inconsistent. 38,42 -44 Human resistin is abundantly expressed in macrophages. 45, 46 Large number of macrophages with higher pro-inflammatory M1/anti-inflammatory M2 macrophages ratio has been detected in EAT of CAD patients compared with non-CAD patients in several studies. 29, 47 This constitutes a possible source of resistin in such patients and suggest a role for this adipokine as a plausible mechanistic link between EAT, inflammation, and atherosclerosis.
Hepatic fat and EAT
Hepatic fat has been widely used as an alternative marker of visceral adipose amount. In fact, liver fat content appears to be the best independent predictor of IR 48 and might play a role in the pathogenesis of cardiovascular disease through the systemic release of atherogenic lipoprotein particles, and several inflammatory, haemostatic, and oxidative-stress mediators. 49 To date, this study is the first to demonstrate significant correlation between MRI-measured EAT volume and hepatic fat fraction. However, the relation was not maintained in the multivariate regression model. Lai et al. 2 and Colak et al. 50 reported significantly higher echocardiographic EAT thickness in patients with non-alcoholic fatty liver disease. This may further provide a link between epicardial fat deposition and abnormal visceral fat metabolism.
In conclusion, peri-coronary epicardial adipose tissue volume is significantly associated with the extent and severity of coronary atherosclerosis and may be a determinant of plaque vulnerability. It may serve as a more sensitive and specific marker of cardiovascular risk than other fat measures. Ultimately, with a better understanding of the determinants of epicardial fat accumulation and the underlying mechanisms of the link between EAT and CAD 'resistin', new therapeutic targets may be identified for prevention of coronary heart disease.
Limitations
(i) The number of patients in this study is relatively small. (ii) It is a cross-sectional study, and the patients were highly selected. However, although our results are based on data obtained in men with stable CAD, we do not know any mechanistic reason that prevents our findings to be applied to women or patients with ACS. (iii) The accuracy of MDCT plaque volume quantification is hampered by calcium blooming effect and the presence of motion artifacts.
